Form 8-K - Current report:
SEC Accession No. 0001193125-26-117888
Filing Date
2026-03-20
Accepted
2026-03-20 17:04:35
Documents
11
Period of Report
2026-03-16
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20260316.htm   iXBRL 8-K 51711
2 EX-99.1 sprb-ex99_1.htm EX-99.1 185837
3 GRAPHIC img25151992_0.jpg GRAPHIC 8377
  Complete submission text file 0001193125-26-117888.txt   364811

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20260316.xsd EX-101.SCH 31969
14 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20260316_htm.xml XML 4723
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 26779046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)